2013

SANBI receives MRC Flagship award

A team led by Professor Alan Christoffels recently received a MRC flagship award to undertake research on tuberculosis with a focus on developing methods to accelerate the identification of new tuberculosis drug targets. Over the past 4 years, the team has been predicting new drug targets for tuberculosis and predicting the effect of DNA modifications […]

SANBI receives MRC Flagship award Read More »

Coelacanth genome surfaces

An international team of researchers from institutions such as Broad Institute at MIT/Harvard, the South African National Bioinformatics Institute (SANBI) at the University of the Western Cape (UWC) and Rhodes University (RU) has decoded the genome of a creature whose evolutionary history is both enigmatic and illuminating: the African coelacanth. A sea-cave dwelling, five-foot long

Coelacanth genome surfaces Read More »

Researchers at SANBI facilitate low-cost HIV drug resistance testing

The introduction of HIV antiretroviral (ARV) therapy programmes in Southern Africa has substantially reduced the burden of infection in HIV-positive individuals. In fact, the 2012 UNAIDS report estimates that as many as 14 million lives have been saved as a result of the rollout of such programmes throughout the world. There is, however, a problem

Researchers at SANBI facilitate low-cost HIV drug resistance testing Read More »